Evidence map›Paper›PMID 29433562›Full record

ArticleEuropean journal of medical research2018

The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy.

Xing-Guang Zhang, Yan-Qi Zhang, Qian-Peng Cheng, Yi Cao, Jian-Min Sun, Xiao-Feng Lv

Registry-linked trialAbstract readControlled Clinical Trial
In one paragraph

Article in European journal of medical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03174821 (The Impact of Insulin Pump Therapy to Oxidative Stress in Patients With Diabetic Nephropathy), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03174821 nacompletednot on this map

The Impact of Insulin Pump Therapy to Oxidative Stress in Patients With Diabetic Nephropathy

TypeinterventionalSponsorChinese PLA General HospitalRan2010 to 2014Enrolled160ConditionsInsulin Pump Therapy in Treating Diabetic NephropathyArmsInsulin pump
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xing-Guang ZhangDepartment of Endocrinology, PLA Army General Hospital, Beijing, China.
Yan-Qi ZhangChina National Institute of Standardization, Beijing, China.
Qian-Peng ChengDepartment of Endocrinology, PLA Army General Hospital, Beijing, China.
Yi CaoDepartment of Endocrinology, PLA Army General Hospital, Beijing, China.
Jian-Min SunDepartment of Endocrinology, PLA Army General Hospital, Beijing, China.
Xiao-Feng LvDepartment of Endocrinology, PLA Army General Hospital, Beijing, China. xiaofenglv7966@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe oxidative stress resulting from increased production of ROS plays a crucial role in the development of diabetic complications. We aim to explore the relationships between oxidative stress, diabetic nephropathy (DN) and short-term insulin pump intensive therapy (insulin therapy).

methodsLevels of 8-hydroxy-deoxyguanosine (8-OHdG), 3-nitrotyrosine (3-NT), glutathione (GSH), superoxide dismutase (SOD) and Interleukin-6 (IL-6) were estimated before and after 2 weeks of insulin therapy in normal group (NC) and type 2 diabetic (DM) with normal albuminuria (NA), microalbuminuria (MA) and clinical albuminuria (CA).

resultsIn DM group, levels of 8-OHdG and 3-NT were higher than those in NC group (P < 0.05); GSH and SOD were lower (P < 0.05). And their levels changed with urine albumin-creatinine ratio (P < 0.05). After insulin therapy, these derangements were significantly ameliorated and the changes in NA and MA groups were more significant than CA group (P < 0.05). Correlation analysis showed glycated hemoglobin, the course of disease, the HOME-IR and fasting plasma glucose were positively correlated with 8-OHdG and 3-NT, but negatively correlated with GSH and SOD.

conclusionsThe oxidative stress gradually increased with the magnitude of DN, and insulin pump intensive therapy can significantly ameliorate the derangements in the early stage of DN. Trial registration NCT03174821.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAdultAgedBlood GlucoseDeoxyguanosineDiabetic NephropathiesFemaleGlutathioneHemoglobinsHumansInsulinInsulin Infusion SystemsInterleukin-6MaleMiddle AgedOxidative Stress3-nitrotyrosine8-Hydroxy-2'-DeoxyguanosineBlood GlucoseDeoxyguanosineGlutathioneHemoglobinsInsulinInterleukin-6Superoxide DismutaseTyrosineDiabetic nephropathyInsulin pump intensive therapyOxidative stress

Identifiers

PMID29433562
PMCPMC5809915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.